Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on November 4, 2026

Nov. 4, 2026

ZenaTech’s Drone as a Service Signs Nearly US$1 Million in Solar Construction Survey Contracts for a U.S. Utility with Potential for US$2.5 Million in Follow-On Revenue

Indeterminate GlobeNewswire

Nov. 4, 2026

CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light

Indeterminate GlobeNewswire

Nov. 4, 2026

ZJK Joins XPO MSA to Expand Market Opportunities for Precision Hardware in High-Density AI Optics

Indeterminate GlobeNewswire

Nov. 4, 2026

Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)

Indeterminate GlobeNewswire

Nov. 4, 2026

Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC

Indeterminate GlobeNewswire

Nov. 4, 2026

ROC Achieves ISO 27001 Certification to Support Enterprise and Government Procurement

Indeterminate GlobeNewswire

Nov. 4, 2026

Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome

Indeterminate GlobeNewswire

Nov. 4, 2026

Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Nov. 4, 2026

Phathom Pharmaceuticals to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Pivotal Phase 2 Rezatapopt PYNNACLE Data to Be Featured in Late-Breaking Oral Presentation at ENA 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Processa Pharmaceuticals Announces Key Leadership Appointments

Indeterminate GlobeNewswire

Nov. 4, 2026

Sutro Biopharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 4, 2026

Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Twin Disc Announces First Quarter Results

Indeterminate GlobeNewswire

Nov. 4, 2026

Jasper Therapeutics Announces 1-for-30 Reverse Stock Split

Indeterminate GlobeNewswire

Nov. 4, 2026

BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Nov. 4, 2026

UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire

Nov. 4, 2026

Bond CEO to Host Investor Webinar on Strategic Financial Realignment

Indeterminate GlobeNewswire

Nov. 4, 2026

Greenland Mines Welcomes Greenland Parliament’s Approval of Landmark U.S.-Denmark-Greenland Security Agreement

Indeterminate GlobeNewswire

Nov. 4, 2026

Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026

Indeterminate GlobeNewswire